Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Hospitalized COVID-19 Patients
NCT04539873Phase 3Terminated
- Sponsor
- Fundación Universitaria de Ciencias de la Salud
- Start
- Apr 2021
- Primary completion
- Oct 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by Fundación Universitaria de Ciencias de la Salud. Started Apr 2021; status: terminated.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04539873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539873.